Arete Wealth Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-73,350
Closed -$418K 751
2024
Q3
$418K Sell
73,350
-37,950
-34% -$216K 0.04% 417
2024
Q2
$514K Buy
111,300
+26,100
+31% +$121K 0.04% 384
2024
Q1
$696K Buy
85,200
+13,100
+18% +$107K 0.06% 262
2023
Q4
$407K Buy
+72,100
New +$407K 0.03% 463